Rachel Klemovitch, Assistant Editor05.03.24
LifeMD, Inc., a leading provider of virtual primary care services, and Withings Health Solutions, a leader in digital health technology, entered a new strategic partnership to provide LifeMD’s GLP-1 weight-loss patients with Withings in-home health monitoring devices, including the Body Pro 2 scale and the BPM Connect Pro blood pressure monitor.
With these devices, LifeMD provides clinicians with near real-time and actionable patient data that can enhance clinical decision-making, encourage preventive healthcare, and improve long-term outcomes.
“Our partnership with Withings supports a key corporate objective of building a significant chronic care management business,” said Anthony Puopolo, M.D., President, LifeMD Affiliated P.C.s. “Many patients currently treated by our affiliated medical group for weight management have heart disease, diabetes or other chronic conditions. Accessible interaction with a virtual provider — combined with diagnostics, remote patient monitoring and in-home tools like those offered by Withings — can improve patient outcomes and reduce the cost of care for chronic diseases.”
LifeMD’s GLP-1 weight-loss program offers online consultations with licensed clinicians, prescriptions for weight management medications, and orders for full-service laboratory testing. LifeMD hopes to gain a deeper understanding of the effectiveness of GLP-1 treatments with the added health data from Withings’ in-home health monitoring devices.
“By being one of the first to monitor body composition in GLP-1 weight-loss programs, LifeMD is pioneering a comprehensive approach to weight management. This collaboration underscores our shared commitment not just to weight management, but to a deeper understanding of a patient’s health,” said Antoine Robiliard, VP Withings Health Solutions. “LifeMD's dedication to leveraging advanced technology to enhance the patient experience aligns perfectly with our vision. Our cellular devices, with patient engagement features, will help LifeMD’s teams drive consistent patient engagement and benefit from larger datasets to make more informed decisions.”
Withings’ Body Pro 2 is a cellular body composition scale that measures weight and provides a body composition analysis that includes body fat, muscle mass, water percentage, and bone mass.
The BPM Connect Pro provides medically accurate blood pressure monitoring, enabling healthcare providers to track changes in blood pressure alongside weight-loss progress. BPM Connect Pro offers a comprehensive view of patient progress and the knowledge clinicians need to adjust patients’ medications.
Both devices use cellular connectivity, ensuring that LifeMD receives HIPAA-compliant, accurate, and reliable measurements continuously, displayed in near real-time via the LifeMD patient portal for use by the patient and clinical team.
This partnership is a significant advancement in GLP-1 weight-loss treatment and exemplifies the potential of digital health technology to transform patient care and outcomes in the virtual care landscape.
With these devices, LifeMD provides clinicians with near real-time and actionable patient data that can enhance clinical decision-making, encourage preventive healthcare, and improve long-term outcomes.
“Our partnership with Withings supports a key corporate objective of building a significant chronic care management business,” said Anthony Puopolo, M.D., President, LifeMD Affiliated P.C.s. “Many patients currently treated by our affiliated medical group for weight management have heart disease, diabetes or other chronic conditions. Accessible interaction with a virtual provider — combined with diagnostics, remote patient monitoring and in-home tools like those offered by Withings — can improve patient outcomes and reduce the cost of care for chronic diseases.”
LifeMD’s GLP-1 weight-loss program offers online consultations with licensed clinicians, prescriptions for weight management medications, and orders for full-service laboratory testing. LifeMD hopes to gain a deeper understanding of the effectiveness of GLP-1 treatments with the added health data from Withings’ in-home health monitoring devices.
“By being one of the first to monitor body composition in GLP-1 weight-loss programs, LifeMD is pioneering a comprehensive approach to weight management. This collaboration underscores our shared commitment not just to weight management, but to a deeper understanding of a patient’s health,” said Antoine Robiliard, VP Withings Health Solutions. “LifeMD's dedication to leveraging advanced technology to enhance the patient experience aligns perfectly with our vision. Our cellular devices, with patient engagement features, will help LifeMD’s teams drive consistent patient engagement and benefit from larger datasets to make more informed decisions.”
Withings’ Body Pro 2 is a cellular body composition scale that measures weight and provides a body composition analysis that includes body fat, muscle mass, water percentage, and bone mass.
The BPM Connect Pro provides medically accurate blood pressure monitoring, enabling healthcare providers to track changes in blood pressure alongside weight-loss progress. BPM Connect Pro offers a comprehensive view of patient progress and the knowledge clinicians need to adjust patients’ medications.
Both devices use cellular connectivity, ensuring that LifeMD receives HIPAA-compliant, accurate, and reliable measurements continuously, displayed in near real-time via the LifeMD patient portal for use by the patient and clinical team.
This partnership is a significant advancement in GLP-1 weight-loss treatment and exemplifies the potential of digital health technology to transform patient care and outcomes in the virtual care landscape.